-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Etho Climate Leadership Index - US (the "index"). The index tracks the performance of the equity securities of a diversified set of U.S. companies that are leaders in their industry with respect to their carbon impact. "Carbon impact" calculated based on the total greenhouse gas ("GHG") emissions from a company's operations, fuel use, supply chain, and business activities, divided by the company's market capitalization. The fund will invest at least 80% of its total assets in the component securities of the index.
Company Website : www.ise.com/
Currency: USD
Country : USA
Inception Date: 18/11/2015
Primary Benchmark: Etho Climate Leadership TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: NA%
Management Expense Ratio: 0.45 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
AUTL | Autolus Therapeutics Ltd | 0.72 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
SOJE | SOJE | 0.00 % |
-0.08 (-0.39%) |
USD 65.72B |
ITDC | Ishares Lifepath Target Date 2.. | 0.00 % |
+0.16 (+0.56%) |
USD 36.86B |
JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
+0.35 (+0.61%) |
USD 32.78B |
LCR | Leuthold Core ETF | 0.00 % |
+0.22 (+0.66%) |
USD 32.52B |
DTB | DTB | 0.00 % |
-0.30 (-1.44%) |
USD 26.58B |
DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
+0.38 (+1.21%) |
USD 26.11B |
JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
+0.02 (+0.04%) |
USD 22.47B |
SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.05 (+0.05%) |
USD 18.58B |
TSPA | T. Rowe Price US Equity Resear.. | 0.00 % |
+0.24 (+0.72%) |
USD 16.23B |
DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.63 (+1.57%) |
USD 10.15B |
N/A
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 24.44% | 89% | A- | 79% | B- | ||
Dividend Return | 0.44% | 12% | F | 8% | B- | ||
Total Return | 24.88% | 89% | A- | 77% | C+ | ||
Trailing 12 Months | |||||||
Capital Gain | 9.68% | 88% | B+ | 79% | B- | ||
Dividend Return | 0.86% | 19% | F | 13% | F | ||
Total Return | 10.53% | 87% | B+ | 74% | C | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | F | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | N/A | N/A | N/A | N/A | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 10.80% | 89% | A- | 67% | D+ | ||
Dividend Return | 11.39% | 89% | A- | 65% | D | ||
Total Return | 0.60% | 50% | F | 16% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 9.89% | 72% | C | 86% | B+ | ||
Risk Adjusted Return | 115.21% | 100% | F | 96% | N/A | ||
Market Capitalization | 0.05B | 40% | F | 17% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.